Kingswood Wealth Advisors LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 33.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,526 shares of the healthcare conglomerate's stock after purchasing an additional 3,394 shares during the period. Kingswood Wealth Advisors LLC's holdings in UnitedHealth Group were worth $7,080,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the 4th quarter valued at $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $32,000. 87.86% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several analysts have recently weighed in on UNH shares. TD Cowen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective on the stock. in a research report on Monday, May 19th. Oppenheimer lowered their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Royal Bank Of Canada decreased their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Finally, TD Securities reiterated a "hold" rating and issued a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $426.52.
View Our Latest Analysis on UNH
Insider Buying and Selling
In other news, Director Kristen Gil bought 3,700 shares of the company's stock in a transaction dated Thursday, May 15th. The shares were purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of the company's stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock valued at $31,607,768 over the last quarter. Corporate insiders own 0.28% of the company's stock.
UnitedHealth Group Trading Up 0.5%
Shares of UNH opened at $309.14 on Wednesday. The firm's 50-day moving average price is $376.32 and its 200-day moving average price is $469.08. The firm has a market capitalization of $280.43 billion, a price-to-earnings ratio of 12.95, a PEG ratio of 1.44 and a beta of 0.44. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the firm posted $6.91 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.86%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is presently 37.02%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.